TD-GC-MS Investigation of the vocs Released from Blood Plasma of Dogs with Cancer

Roman Selyanchyn, Takuma Nozoe, Hidetaka Matsui, Tsuyoshi Kadosawa, Seung Woo Lee

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)


An analytical TD-GC-MS method was developed and used for the assessment of volatile organic compounds (VOCs) released from the blood plasma of dogs with/without cancer. VOCs released from 40 samples of diseased blood and 10 control samples were compared in order to examine the difference between both sample groups that were showing qualitatively similar results independent from the disease's presence. However, mild disturbances in the spectra of dogs with cancer in comparison with the control group were observed, and six peaks (tentatively identified by comparison with mass spectral library as hexanal, octanal, toluene, 2-butanone, 1-octen-3-ol and pyrrole) revealed statistically significant differences between both sample groups, thereby suggesting that these compounds are potential biomarkers that can be used for cancer diagnosis based on the blood plasma TD-GC-MS analysis. Statistical comparison with the application of principal component analysis (PCA) provided accurate discrimination between the cancer and control groups, thus demonstrating stronger biochemical perturbations in blood plasma when cancer is present.

Original languageEnglish
Pages (from-to)68-83
Number of pages16
Issue number1
Publication statusPublished - 2013
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry


Dive into the research topics of 'TD-GC-MS Investigation of the vocs Released from Blood Plasma of Dogs with Cancer'. Together they form a unique fingerprint.

Cite this